We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Tracking TRDA? Get live short interest, options flow, and signals on ORTEX.Sign up free →
TR

Entrada Therapeutics, Inc. (TRDA) short interest & options flow

NASDAQ

Entrada Therapeutics heads into its May 8 earnings event carrying a story that goes well beyond the financials — topline data from its lead DMD programme drops on May 7, the day before the print. The company announced late on May 6 that it will release Cohort 1 results from the Phase 1/2 ELEVATE-44-201 study of ENTR-601-44, its exon-44 skipping candidate for Duchenne Muscular…

$5.44+3.62% 1d+7.51% 1w-4.06% 1mClose: 11 Nov 2026
Short interest % of float
Dropping
Live SI on ORTEX →
Cost to borrow
Low and dropping
Live CTB on ORTEX →
Market cap
$199M
Next earnings
26 Feb 2027
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 12 Nov 2026

ORTEX chart of Entrada Therapeutics, Inc. (TRDA) share price and short interest (% of free float), six months to November 11, 2026

TRDA news and analysis

RSS

No long-form analysis yet for TRDA. Pulse alerts and the live data picture are available on ORTEX.

Open TRDA on ORTEX →

Want the live picture for TRDA?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TRDA — free to start on ORTEX.

Sign up for free →Open TRDA on ORTEX